期刊文献+

舒芬太尼在体外人肝微粒体中代谢速率的测定 被引量:4

Measurement of metabolic rate of sufentanil in vitro of human hepatic microsome
原文传递
导出
摘要 目的:建立高效液相色谱法(HPLC)测定人肝脏微粒体中舒芬太尼的药物浓度,为进一步研究舒芬太尼的药物代谢提供新方法。方法:于人体肝组织微粒体孵育液中加入舒芬太尼,用HPLC测定孵育液中不同时点的舒芬太尼浓度,以芬太尼为内标,用正己烷-无水乙醇(19∶1)进行萃取,采用Diamonsil C18色谱柱(4.6 mm×200 mm,5μm),以乙腈-0.015 mol.L-1KH2PO4缓冲液(31∶69,pH3.0)为流动相,流速1.0mL.min-1,检测波长205 nm,进样量50μL。结果:在0.125~3 mg.L-1范围内,舒芬太尼线性关系良好(r=0.999 5),最低检测为0.1 mg.L-1,回收率为90.66%~100.02%,24例人肝脏微粒体中平均每毫克蛋白的舒芬太尼的代谢速率为(0.19±0.06)nmol.min-1;舒芬太尼与内标芬太尼分离完全,不受微粒体内源性物质的干扰,保留时间分别为9.588 min和4.765 min。结论:HPLC检测体外孵育液中肝微粒体中的舒芬太尼灵敏度高,专一性强,适用于药物体外代谢速率的研究。 OBJECTIVE To establish an HPLC method for determining the concentrations of sufentanil in human liver microsomes,and to provide a new way for investigating the metabolism of sufentanil.METHODS Sufentanil in an incubation mixture with human liver microsomes was determined by high performance liquid chromatography(HPLC) at the different time points,to calculate the metabolic rate of sufentanil.Fentanyl was used as an internal standard.The samples were extracted by liquid-liquid extraction method using n-hexane and ethanol(19∶1).Sufentanil was determined by HPLC using of 0.015 mol·L-1 potassium,acetonitrile(31∶69,pH 3.0)was pumped at 1.0 mL·min-1 and the wavelength of detection was set at 205 nm,50 μL of sample was injected.RESULTS The assay was linear over the range of 0.125-3 mg·L-1 for sufentanil(r=0.999 5),the limit of detection was 0.1 mg·L-1.The method afforded recoveries was 90.66%-100.02%.The metabolic rate of sufentanil in the twenty four cases of microsomes was(0.19±0.06) nmol·min-1.On the condition of this study sufentanil was totally separated with internal standard fentanyl and suffered no endogenous material intervention.Retention time of sufentanil and internal standard fentanyl was 9.588 min and 4.765 min respectively.CONCLUSION HPLC method is sensitive and specific to detect the metabolic rate of sufentanil in human hepatic microsome and helpful to investigate the metabolism of drugs in vitro.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2011年第16期1342-1344,共3页 Chinese Journal of Hospital Pharmacy
基金 贝朗麻醉科学研究基金(2008年1月)
关键词 舒芬太尼 高效液相色谱 肝微粒体 sufentanil high-performance liquid chromatography hepatic microsomes
  • 相关文献

参考文献2

二级参考文献4

共引文献46

同被引文献37

  • 1曹全胜,隋宁海,吕航.高效液相色谱法测定枸橼酸芬太尼注射液的含量[J].中国医院药学杂志,1994,14(8):343-344. 被引量:5
  • 2Feierman DE, Lasker JM. Metabolism of fentauyl, a synthetic opioid analgesic, by human liver micrusomes. Role of CYP3A4[ J]. Drug Metab Dispos, 1996,24(9) : 932-939.
  • 3Portier EJ, de Blok K, Butter JJ, et al. Simultaneous determination of fentanyl and midazolam using high-performance liquid chromatography with ultraviolet detection[J]. J Chrumatogr B Biomed Sci Appl, 1999,723(1-2) : 313-318.
  • 4Labroo RB, Paine MF, Thummel KE,et al, Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactinns[J]. Drug Meiab Dispos, 1997,25(9): 1072-1080.
  • 5Tateishi T, Krivoruk Y, Ueng YF,et al, Identification of human liver cytochrome P-g50 3A4 as the enzyme responsible for fentanyl and sufentanil N-dealkylation [ J ]. Anesth Analg, 1996, 82 ( 1 ) : 167- 172.
  • 6Court MH, Duan SX, Hesse LM , et al. Cytochrome P-450 2B6 is responsible for interindividual variability of propofol hydroxylati0n by human liver microsomes[ J ]. Anesthesiology, 2001,94( 1 ) : 110-119.
  • 7Tan PC, Hassan SK, Mohamad NA, et al. Cytochrome P450 3A4 genetic polymorphisms and post-operative fentanyl requirements[J] . J Clin Pharm Ther, 2012,37( 1 ) : 100-104.
  • 8Pisake L,Malinee L,Gulmezoglu AM,et al.Method of deliveryand pregnancy outcome in Asia:the WHO global survey on maternal and perinatal health 2007-2008[J].Lancet,2010,375:490-499.
  • 9Vande Velde M,Teunkens A,Hanssens M,et a1.Intrathe-cal sufentanil and fetal heart rate abnormalities:a doubleblind.double placebo-controlled trial comparing two forms of combined spinal epidural analgesia with epidural anal-gesia in labor[J].Anesth Analg,2004,98(4):1153-1159.
  • 10Salem IC,Fukushima FB,Nakamura G,et a1.Side effects of subaraehnoid and epidural sufentanil associated with a local anesthetic in patients undergoing labor analgesia[J].Rev Bras Anestesi,2007,57(2):125-135.

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部